Polymer Capital Management (HK)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Polymer Capital Management (HK)'s REGN Position: Q2 2026 in Review
Polymer Capital Management (HK) increased its Regeneron Pharmaceuticals (REGN) stake by 194% in Q2 2026, buying an estimated $1.66M and bringing the position to 3,704 shares worth $2.31M. The position accounts for 0.12% of the portfolio, ranked #85.
Polymer Capital Management (HK) first reported a position in REGN in Q1 2026 and has held it in 2 quarters since. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Polymer Capital Management (HK) held 3,704 shares of Regeneron Pharmaceuticals worth $2.31M as of Q2 2026.
- Polymer Capital Management (HK) bought 2,445 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.66M.
- Regeneron Pharmaceuticals made up 0.12% of Polymer Capital Management (HK)'s portfolio in Q2 2026, its #85 holding.
- Polymer Capital Management (HK) first reported a position in Regeneron Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Polymer Capital Management (HK)'s 13F filing for Q2 2026, filed 13 Aug 2026.